Publications

Androgen Receptor Modulation Optimized for Response (ARMOR) Phase I and II Studies: Galeterone for the Treatment of Castration-Resistant Prostate Cancer

Discovery and development of Galeterone (TOK-001 or VN/124-1) for the treatment of all stages of prostate cancer

Large-scale synthesis of galeterone and lead next generation galeterone analog VNPP433-3β

Efficacy of Therapies After Galeterone in Patients With Castration-resistant Prostate Cancer

Galeterone sensitizes breast cancer to chemotherapy via targeting MNK/eIF4E and β-catenin

Galeterone for the treatment of advanced prostate cancer: the evidence to date